{"transactions":[{"id":723943,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T23:49:41.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":52084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":52084},"source":{"system":"sec-edgar","filing":"0001229765-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000008/form4.xml","form_type":"4"}},{"id":723942,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-29T23:49:41.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":52084,"price":20.18,"value":1051055.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001229765-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000008/form4.xml","form_type":"4"}},{"id":723941,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-29T23:49:41.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":52084,"price":7.8,"value":406255.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025."}],"balance_after":67709,"source":{"system":"sec-edgar","filing":"0001229765-26-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000008/form4.xml","form_type":"4"}},{"id":843865,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-14T01:05:15.000Z","date":"2026-03-11","kind":"sale","planned":false,"acquired":false,"shares":15394,"price":13.91,"value":214130.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $13.84 to $13.96, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001229765-26-000006","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000006/form4.xml","form_type":"4"}},{"id":855838,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-07T00:08:49.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31019,"source":{"system":"sec-edgar","filing":"0001229765-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000004/form4.xml","form_type":"4"}},{"id":858281,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-06T01:05:19.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":false,"shares":48044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":48044},"source":{"system":"sec-edgar","filing":"0001229765-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000001/primary_doc.xml","form_type":"4"}},{"id":858280,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T01:05:19.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":48044,"price":15.3,"value":735073.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.11 to $15.54, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":15394,"source":{"system":"sec-edgar","filing":"0001229765-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000001/primary_doc.xml","form_type":"4"}},{"id":858279,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T01:05:19.000Z","date":"2026-03-03","kind":"exercise","planned":true,"acquired":true,"shares":48044,"price":3.99,"value":191695.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 7, 2025."}],"balance_after":63438,"source":{"system":"sec-edgar","filing":"0001229765-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000122976526000001/primary_doc.xml","form_type":"4"}},{"id":1203685,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-17T23:33:54.000Z","date":"2025-03-13","kind":"sale","planned":false,"acquired":false,"shares":36291,"price":7.19,"value":260932.29,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.15 to $7.25, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":15394,"source":{"system":"sec-edgar","filing":"0001062993-25-005644","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325005644/form4.xml","form_type":"4"}},{"id":1219459,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-07T00:14:27.000Z","date":"2025-03-04","kind":"grant","planned":true,"acquired":true,"shares":23726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates."}],"balance_after":23726,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":23726},"source":{"system":"sec-edgar","filing":"0001062993-25-004800","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004800/form4.xml","form_type":"4"}},{"id":1219458,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T00:14:27.000Z","date":"2025-03-06","kind":"sale","planned":true,"acquired":false,"shares":15664,"price":7.94,"value":124372.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.64 to $8.21, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":51685,"source":{"system":"sec-edgar","filing":"0001062993-25-004800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004800/form4.xml","form_type":"4"}},{"id":1219457,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T00:14:27.000Z","date":"2025-03-04","kind":"grant","planned":true,"acquired":true,"shares":15394,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":67349,"source":{"system":"sec-edgar","filing":"0001062993-25-004800","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299325004800/form4.xml","form_type":"4"}},{"id":1591567,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-07T00:43:59.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":48044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates."}],"balance_after":48044,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":48044},"source":{"system":"sec-edgar","filing":"0001062993-24-005770","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005770/form4.xml","form_type":"4"}},{"id":1591566,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-07T00:43:59.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":31328,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":51955,"source":{"system":"sec-edgar","filing":"0001062993-24-005770","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299324005770/form4.xml","form_type":"4"}},{"id":1809809,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:09:17.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13300,"price":26.12,"value":347396.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option award, which vested in full upon the earlier of the one year anniversary of the grant date or the date of the Issuer's next annual stockholders' meeting, was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":13.88,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001209191-23-045422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045422/doc4.xml","form_type":"4"}},{"id":1809808,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:09:17.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5948,"price":23.19,"value":137934.12,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option award, which vested in full upon the earlier of the one year anniversary of the grant date or the date of the Issuer's next annual stockholders' meeting, was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":16.81,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":5948},"source":{"system":"sec-edgar","filing":"0001209191-23-045422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045422/doc4.xml","form_type":"4"}},{"id":1809807,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-11T16:09:17.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23522,"price":25.23,"value":593460.06,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award, which provided for ratable vesting in 36 monthly installments beginning on November 6, 2020, became fully vested and was canceled upon effectiveness of the Merger, and was converted into the right to receive, with respect to each share of the Issuer's Common Stock underlying such option, (i) a cash payment representing the excess, if any, of the per share merger consideration ($40.00 per share) over the per share exercise price for such option, without interest, and (ii) one CVR, entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement entered into concurrent with the completion of the Merger, in each case subject to applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":14.77,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":23522},"source":{"system":"sec-edgar","filing":"0001209191-23-045422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045422/doc4.xml","form_type":"4"}},{"id":1809806,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-11T16:09:17.000Z","date":"2023-08-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were disposed of pursuant to the Merger Agreement (defined in the Remarks below).  Upon effectiveness of the Merger (defined in the Remarks below), in exchange for each share of the Issuer's Common Stock, the reporting person received:  (i) $40.00 in cash, without interest and less applicable withholding taxes; and (ii) one contractual contingent value right (each, a \"CVR\"), entitling the reporting person to additional cash payments upon the achievement of certain future business milestones pursuant to the Contingent Value Rights Agreement (the \"Contingent Value Rights Agreement\") entered into concurrent with completion of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-045422","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123045422/doc4.xml","form_type":"4"}},{"id":1873257,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-31T19:23:26.000Z","date":"2023-05-26","kind":"exercise","planned":false,"acquired":false,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the RSUs vested on May 26, 2023, subject to the Reporting Persons continued service to the Issuer on the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001209191-23-033188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123033188/doc4.xml","form_type":"4"}},{"id":1873256,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T19:23:26.000Z","date":"2023-05-26","kind":"exercise","planned":false,"acquired":true,"shares":3300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":3300,"source":{"system":"sec-edgar","filing":"0001209191-23-033188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919123033188/doc4.xml","form_type":"4"}},{"id":1935664,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-29T21:01:50.000Z","date":"2023-03-27","kind":"sale","planned":false,"acquired":false,"shares":2341,"price":8.4913,"value":19878.1333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.41 to $8.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":20627,"source":{"system":"sec-edgar","filing":"0001062993-23-008033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323008033/form4.xml","form_type":"4"}},{"id":1950646,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-16T16:37:10.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, which is made as part of the Issuer's 2023 annual compensation cycle, vests and becomes exercisable in full on March 14, 2024."}],"balance_after":20000,"derivative":{"exercise_price":1.67,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-019317","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919123019317/doc4.xml","form_type":"4"}},{"id":1963189,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:06:36.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":23329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates."}],"balance_after":23329,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":23329},"source":{"system":"sec-edgar","filing":"0001062993-23-006333","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006333/form4.xml","form_type":"4"}},{"id":1963188,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:06:36.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":14775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22968,"source":{"system":"sec-edgar","filing":"0001062993-23-006333","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000106299323006333/form4.xml","form_type":"4"}},{"id":2158612,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-09-15T18:12:42.000Z","date":"2022-09-15","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest on the earlier of September 15, 2023 or the date of the next annual meeting of stockholders."}],"balance_after":4000,"derivative":{"exercise_price":0.86,"expiration_date":"2032-09-14","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-22-050149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919122050149/doc4.xml","form_type":"4"}},{"id":2251266,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-31T18:40:17.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the RSUs will vest on May 26, 2023, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":3300,"derivative":{"expiration_date":"2023-05-26","underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001209191-22-032971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122032971/doc4.xml","form_type":"4"}},{"id":2251265,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-31T18:40:17.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":13300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the stock option will vest on May 26, 2023, subject to the Reporting Person's continued service to the Issuer on the vesting date."}],"balance_after":13300,"derivative":{"exercise_price":13.88,"expiration_date":"2032-05-25","underlying":"Common Stock","underlying_shares":13300},"source":{"system":"sec-edgar","filing":"0001209191-22-032971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919122032971/doc4.xml","form_type":"4"}},{"id":2422474,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-29T00:00:32.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":16722,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":16722,"derivative":{"exercise_price":14.95,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":16722},"source":{"system":"sec-edgar","filing":"0001209191-22-005497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122005497/doc4.xml","form_type":"4"}},{"id":2422473,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-29T00:00:32.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":6689,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8193,"source":{"system":"sec-edgar","filing":"0001209191-22-005497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919122005497/doc4.xml","form_type":"4"}},{"id":2432768,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-19T16:22:03.000Z","date":"2022-01-14","kind":"grant","acquired":true,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on January 14, 2023."}],"balance_after":18500,"derivative":{"exercise_price":2.21,"expiration_date":"2032-01-14","underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0001209191-22-003718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919122003718/doc4.xml","form_type":"4"}},{"id":2586567,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-31T00:00:33.000Z","date":"2021-08-27","kind":"exercise","acquired":false,"shares":14916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":52084,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":14916},"source":{"system":"sec-edgar","filing":"0001209191-21-053971","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121053971/doc4.xml","form_type":"4"}},{"id":2586566,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T00:00:33.000Z","date":"2021-08-27","kind":"sale","acquired":false,"shares":14916,"price":35,"value":522060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-053971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121053971/doc4.xml","form_type":"4"}},{"id":2586565,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-31T00:00:33.000Z","date":"2021-08-27","kind":"exercise","acquired":true,"shares":14916,"price":7.8,"value":116344.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":16420,"source":{"system":"sec-edgar","filing":"0001209191-21-053971","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121053971/doc4.xml","form_type":"4"}},{"id":2596554,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-19T17:21:27.000Z","date":"2021-08-18","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest on the earlier of August 18, 2022 or the date of the next annual meeting of stockholders."}],"balance_after":4000,"derivative":{"exercise_price":6.25,"expiration_date":"2031-08-17","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-052589","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919121052589/doc4.xml","form_type":"4"}},{"id":2630507,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-20T01:00:24.000Z","date":"2021-07-14","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":67000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-047303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121047303/doc4.xml","form_type":"4"}},{"id":2630506,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T01:00:24.000Z","date":"2021-07-14","kind":"sale","acquired":false,"shares":2500,"price":36.8,"value":92000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-047303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121047303/doc4.xml","form_type":"4"}},{"id":2630505,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-20T01:00:24.000Z","date":"2021-07-14","kind":"exercise","acquired":true,"shares":2500,"price":7.8,"value":19500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":4004,"source":{"system":"sec-edgar","filing":"0001209191-21-047303","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121047303/doc4.xml","form_type":"4"}},{"id":2660887,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T00:00:27.000Z","date":"2021-06-17","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":69500,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-21-042289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121042289/doc4.xml","form_type":"4"}},{"id":2660886,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T00:00:27.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":4000,"price":40,"value":160000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-042289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121042289/doc4.xml","form_type":"4"}},{"id":2660885,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-22T00:00:27.000Z","date":"2021-06-17","kind":"exercise","acquired":true,"shares":4000,"price":7.8,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":5504,"source":{"system":"sec-edgar","filing":"0001209191-21-042289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121042289/doc4.xml","form_type":"4"}},{"id":2666247,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T23:00:27.000Z","date":"2021-06-14","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":73500,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-041089","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121041089/doc4.xml","form_type":"4"}},{"id":2666246,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T23:00:27.000Z","date":"2021-06-14","kind":"sale","acquired":false,"shares":2500,"price":38.56,"value":96400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-041089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121041089/doc4.xml","form_type":"4"}},{"id":2666245,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T23:00:27.000Z","date":"2021-06-14","kind":"exercise","acquired":true,"shares":2500,"price":7.8,"value":19500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":4004,"source":{"system":"sec-edgar","filing":"0001209191-21-041089","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121041089/doc4.xml","form_type":"4"}},{"id":2679178,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-07T21:35:43.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":5948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award will fully vest upon the earlier of 1) the Issuer's next annual stockholder meeting, or 2) June 4, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5948,"derivative":{"exercise_price":16.81,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":5948},"source":{"system":"sec-edgar","filing":"0001209191-21-038797","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919121038797/doc4.xml","form_type":"4"}},{"id":2705433,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T00:00:19.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":76000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-034235","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121034235/doc4.xml","form_type":"4"}},{"id":2705432,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T00:00:19.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":2500,"price":35,"value":87500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-034235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121034235/doc4.xml","form_type":"4"}},{"id":2705431,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-20T00:00:19.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":2500,"price":7.8,"value":19500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":4004,"source":{"system":"sec-edgar","filing":"0001209191-21-034235","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121034235/doc4.xml","form_type":"4"}},{"id":2747009,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-17T01:00:15.000Z","date":"2021-04-14","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":78500,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-027123","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121027123/doc4.xml","form_type":"4"}},{"id":2747008,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-17T01:00:15.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":4500,"price":43.41,"value":195345.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-027123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121027123/doc4.xml","form_type":"4"}},{"id":2747007,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-17T01:00:15.000Z","date":"2021-04-14","kind":"exercise","acquired":true,"shares":4500,"price":7.8,"value":35100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":6004,"source":{"system":"sec-edgar","filing":"0001209191-21-027123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121027123/doc4.xml","form_type":"4"}},{"id":2782228,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":83000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2782227,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":84500,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2782226,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-16","kind":"sale","acquired":false,"shares":1500,"price":47,"value":70500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2782225,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":1500,"price":7.8,"value":11700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":3004,"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2782224,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":3609,"price":41.89,"value":151181.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $41.51 to 42.23, inclusive."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2782223,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":891,"price":41.17,"value":36682.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $40.51 to 41.50, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":5113,"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2782222,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T23:00:52.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":4500,"price":7.8,"value":35100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":6004,"source":{"system":"sec-edgar","filing":"0001209191-21-021550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121021550/doc4.xml","form_type":"4"}},{"id":2858985,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T01:26:12.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":89000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-21-011065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011065/doc4.xml","form_type":"4"}},{"id":2858984,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-17T01:26:12.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":3759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":3759,"derivative":{"exercise_price":66.5,"expiration_date":"2031-02-14","underlying":"Common Stock","underlying_shares":3759},"source":{"system":"sec-edgar","filing":"0001209191-21-011065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011065/doc4.xml","form_type":"4"}},{"id":2858983,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T01:26:12.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":6000,"price":65.08,"value":390480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $64.49 to 65.45, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-011065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011065/doc4.xml","form_type":"4"}},{"id":2858982,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T01:26:12.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":6000,"price":7.8,"value":46800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":7504,"source":{"system":"sec-edgar","filing":"0001209191-21-011065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011065/doc4.xml","form_type":"4"}},{"id":2858981,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-17T01:26:12.000Z","date":"2021-02-14","kind":"grant","acquired":true,"shares":1504,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1504,"source":{"system":"sec-edgar","filing":"0001209191-21-011065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121011065/doc4.xml","form_type":"4"}},{"id":2903005,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-20T16:14:11.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on January 15, 2022."}],"balance_after":15000,"derivative":{"exercise_price":3.85,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-004276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919121004276/doc4.xml","form_type":"4"}},{"id":2905890,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-16T01:00:09.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":95000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-21-003914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121003914/doc4.xml","form_type":"4"}},{"id":2905889,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-16T01:00:09.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":959,"price":66.43,"value":63706.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $66.25 to 66.65, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-003914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121003914/doc4.xml","form_type":"4"}},{"id":2905888,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-16T01:00:09.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":5041,"price":65.77,"value":331546.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $65.25 to 66.18, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":959,"source":{"system":"sec-edgar","filing":"0001209191-21-003914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121003914/doc4.xml","form_type":"4"}},{"id":2905887,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-16T01:00:09.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":6000,"price":7.8,"value":46800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-21-003914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919121003914/doc4.xml","form_type":"4"}},{"id":2942459,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-17T02:00:08.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":101000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-20-063930","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120063930/doc4.xml","form_type":"4"}},{"id":2942458,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T02:00:08.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":1651,"price":59.44,"value":98135.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $59.25 to 59.90, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-063930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120063930/doc4.xml","form_type":"4"}},{"id":2942457,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T02:00:08.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":3367,"price":58.96,"value":198518.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $58.25 to 59.24, inclusive."}],"balance_after":1651,"source":{"system":"sec-edgar","filing":"0001209191-20-063930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120063930/doc4.xml","form_type":"4"}},{"id":2942456,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T02:00:08.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":982,"price":57.42,"value":56386.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $57.08 to 57.99, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":5018,"source":{"system":"sec-edgar","filing":"0001209191-20-063930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120063930/doc4.xml","form_type":"4"}},{"id":2942455,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-17T02:00:08.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":6000,"price":7.8,"value":46800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-063930","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120063930/doc4.xml","form_type":"4"}},{"id":2975152,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T02:00:12.000Z","date":"2020-11-16","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":107000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-20-059291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120059291/doc4.xml","form_type":"4"}},{"id":2975151,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T02:00:12.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":979,"price":48.3,"value":47285.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $48.00 to 48.50, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-059291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120059291/doc4.xml","form_type":"4"}},{"id":2975150,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T02:00:12.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":5021,"price":47.57,"value":238848.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $47.05 to 47.99, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":979,"source":{"system":"sec-edgar","filing":"0001209191-20-059291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120059291/doc4.xml","form_type":"4"}},{"id":2975149,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-19T02:00:12.000Z","date":"2020-11-16","kind":"exercise","acquired":true,"shares":6000,"price":7.8,"value":46800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-20-059291","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120059291/doc4.xml","form_type":"4"}},{"id":3005219,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-16T21:00:11.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":113000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-04-23","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-055069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055069/doc4.xml","form_type":"4"}},{"id":3005218,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:11.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":7351,"price":53.07,"value":390117.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $52.86 to 53.36, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-055069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055069/doc4.xml","form_type":"4"}},{"id":3005217,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:11.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":4649,"price":52.48,"value":243979.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $51.85 to 52.834, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":7351,"source":{"system":"sec-edgar","filing":"0001209191-20-055069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055069/doc4.xml","form_type":"4"}},{"id":3005216,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:11.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":12000,"price":7.8,"value":93600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-20-055069","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120055069/doc4.xml","form_type":"4"}},{"id":3010806,"issuer":{"id":110632,"kind":"organization","name":"CHINOOK THERAPEUTICS, INC.","symbol":"KDNY"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-07T21:04:47.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":23522,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on November 6, 2020 until fully vested, subject to the Reporting\nPerson's provision of service to the Issuer on each vesting date."}],"balance_after":23522,"derivative":{"exercise_price":14.77,"expiration_date":"2030-10-05","underlying":"Common Stock","underlying_shares":23522},"source":{"system":"sec-edgar","filing":"0001209191-20-054249","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435049/000120919120054249/doc4.xml","form_type":"4"}},{"id":3050088,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-21T16:53:05.000Z","date":"2020-08-19","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest on the earlier of August 19, 2021 or the date of the next annual meeting of stockholders."}],"balance_after":60000,"derivative":{"exercise_price":0.46,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-047957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919120047957/doc4.xml","form_type":"4"}},{"id":3266743,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-18T12:05:43.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":8888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date."}],"balance_after":8888,"derivative":{"exercise_price":31.71,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":8888},"source":{"system":"sec-edgar","filing":"0001209191-20-009874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000120919120009874/doc4.xml","form_type":"4"}},{"id":3324137,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-03T16:18:32.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on January 2, 2021."}],"balance_after":9000,"derivative":{"exercise_price":3.79,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-000915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919120000915/doc4.xml","form_type":"4"}},{"id":3436440,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-16T16:34:42.000Z","date":"2019-08-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest on the earlier of August 14, 2020 or the date of the next annual meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":1.04,"expiration_date":"2029-08-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-046334","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919119046334/doc4.xml","form_type":"4"}},{"id":3436439,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-16T16:34:42.000Z","date":"2019-08-14","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-19-046334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919119046334/doc4.xml","form_type":"4"}},{"id":3675171,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-05T13:53:34.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in full on February 1, 2020."}],"balance_after":6000,"derivative":{"exercise_price":24.46,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-19-007241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000120919119007241/doc4.xml","form_type":"4"}},{"id":3840377,"issuer":{"id":112530,"kind":"organization","name":"HTG MOLECULAR DIAGNOSTICS, INC","symbol":"HTGM"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-08-17T17:19:58.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares will vest twelve months after August 15, 2018 and the remaining shares will vest monthly in equal installments over a two year period such that the stock option is fully vested on the third anniversary of August 15, 2018."}],"balance_after":20000,"derivative":{"exercise_price":3.31,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-047469","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169987/000120919118047469/doc4.xml","form_type":"4"}},{"id":4190355,"issuer":{"id":108116,"kind":"organization","name":"Acer Therapeutics Inc.","symbol":"ACER"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2017-10-06T16:11:02.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve equal quarterly installments beginning on October 4, 2017."}],"balance_after":9000,"derivative":{"exercise_price":15.34,"expiration_date":"2027-10-04","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001654954-17-009223","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1069308/000165495417009223/section16.xml","form_type":"4"}},{"id":4301163,"issuer":{"id":174777,"kind":"organization","name":"PHASERX, INC.","symbol":"PZRX"},"owners":[{"id":34806,"kind":"person","name":"GRIFFIN MICHELLE RENEE","position":1,"cik":"0001229765","reported_name":"GRIFFIN MICHELLE RENEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-30T17:46:16.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 25, 2017, the reporting person was granted an option to purchase shares of common stock. The option vests in 1/12th equal installments on each monthly anniversary of May 25, 2017, and subject to the reporting person's continued service to the Issuer."}],"balance_after":14000,"derivative":{"exercise_price":1.0799,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001144204-17-030195","document":"v468087_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429386/000114420417030195/v468087_form4.xml","form_type":"4"}}]}